Psilocybin treatment can bring terminal patients understanding and peace. But the government is blocking access.
Curt Petrovich is a journalist with more than 30 years of investigative reporting experience and numerous awards. In 2015, he was diagnosed with severe PTSD stemming from decades covering natural disasters and humanitarian catastrophes. SHARES Cancer patient Thomas Hartle, with Ellie, says psilocybin therapy has been a huge benefit. ‘Even now, I can’t emphasize enough how much of my life it has given back.. Even months later, it’s much easier for me to be able to clear my head of those useless, anxious thoughts.’
Photo from Thomas Hartle.
Topic | Energy storage | Brisbane Times
We’re sorry, this service is currently unavailable. Please try again later.
Dismiss
15 hours ago
March 25, 2021
February 15, 2021
Opinion
January 28, 2021
Science says the switch to renewables needs to be fast but workers say it should also be fair. In the first of our explainer series Future Power, we ask how did Germany do it? And could Australia have a just transition too?
January 11, 2021
Topic | Energy storage | WAtoday
Dismiss
7 hours ago
March 25, 2021
February 15, 2021
Opinion
January 28, 2021
Science says the switch to renewables needs to be fast but workers say it should also be fair. In the first of our explainer series Future Power, we ask how did Germany do it? And could Australia have a just transition too?
January 11, 2021
The 10-week program is designed to prepare health-care practitioners to safely and effectively guide patients through a psilocybin experience, and will culminate in each psychotherapist consuming psilocybin and having their own therapeutic session, as well as guiding a peer through the experience.
Psilocybin is a psychedelic that can produce altered states of consciousness, euphoria, spiritual experiences and a distorted sense of time lasting several hours. It can also have adverse effects such as paranoia and panic attacks.
Bruce Tobin, a clinical psychologist in Victoria and founder of TheraPsil, said when people take psychedelics, they can experience a wider range of emotions.
Article content
Prior to the pandemic, the lifetime prevalence of major depressive disorder in Canada was between 4.7-11.2 per cent, which has equated to a $51 billion burden on the Canadian economy through lost productivity, lowered quality of life, and related healthcare costs. Early reports suggest that these figures have grown significantly, with rates of depression symptoms and suicidal ideation tripling since the start of the pandemic with over half the population reporting worsened mental health due to the impact of the pandemic. Current treatment approaches such as antidepressants struggle with high drop-out, relapse, and non-adherence rates, as well as negligible improvements in symptoms. These issues have warranted an exploration of novel treatment approaches and there is a growing body of research that supports psychedelic-assisted therapy’s ability to address them.